Content
and Copyright
i
Incorporation and Controlled Release of Silyl Ether Prodrugs from PRINT Nanoparticles
-
Published Date:
Apr 30 2012
Publisher's site:Source:J Am Chem Soc. 134(18):7978-7982.
[PDF-1.59 MB]
Details:
-
Alternative Title:J Am Chem Soc
-
Personal Author:
-
Description:Asymmetric bifunctional silyl ether (ABS) prodrugs of chemotherapeutics were synthesized and incorporated within 200 nm × 200 nm particles. ABS prodrugs of gemcitabine were selected as model compounds because of the difficulty to encapsulate a water-soluble drug within a hydrogel. The resulting drug delivery systems were degraded under acidic conditions and were found to release only the parent or active drug. Furthermore, changing the steric bulk of the alkyl substituents on the silicon atom could regulate the rate of drug release and, therefore, the intracellular toxicity of the gemcitabine-loaded particles. This yielded a family of novel nanoparticles that could be tuned to release drug over the course of hours, days, or months.
-
Subject:
-
Pubmed ID:22545784
-
Pubmed Central ID:PMC3362319
-
Document Type:
-
Funding:
-
Collection(s):
-
Main Document Checksum:
- File Type:
-
Supporting Files:
image/gif 
image/jpeg 
image/gif 
image/jpeg 
image/gif 
image/jpeg 
image/gif 
image/jpeg 
application/pdf 
text/xml 
image/gif 
image/jpeg 
image/gif 
image/jpeg 
image/gif 
image/jpeg
No Related Documents.
You May Also Like:
-
Published Date:Source:Description:File Type:[PDF - 2.44 MB]
File Type:[PDF - 2.44 MB]
Published Date:Source:Description:File Type:[PDF - 761.47 KB]
File Type:[PDF - 761.47 KB]
Published Date:Source:File Type:[PDF - 1.64 MB]
File Type:[PDF - 1.64 MB]
Published Date:Source:Description:File Type:[PDF - 1.37 MB]
File Type:[PDF - 1.37 MB]
Published Date:Source:Description:File Type:[PDF - 890.84 KB]
File Type:[PDF - 890.84 KB]
Have Questions?
Visit CDC Info
Email
CDC-INFO
Open 24/7
CDC INFORMATION
CONNECT WITH CDC
